MIST Share Price Performance
US$2.15
0.45 (26.47%)
Price US$2.15
Share Pricen/a
Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet?
Nov 15
Milestone Pharmaceuticals Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 21 Fair Values set on narratives written by author
MIST Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Milestone Pharmaceuticals Inc. Key Details
About MIST
- Founded
- 2003
- Employees
- 33
- CEO
- WebsiteView website
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company’s lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
